- Home
- HCM vs VZLA Comparison
HCM vs VZLA Comparison
Compare HCM & VZLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HCM | VZLA |
|---|---|---|
| Founded | 2000 | 2017 |
| Country | Hong Kong | Canada |
| Employees | 1811 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.2B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | HCM | VZLA |
|---|---|---|
| Price | $14.28 | $3.58 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $13.75 | $7.00 |
| AVG Volume (30 Days) | 20.0K | ★ 9.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $28.37 | N/A |
| Revenue Next Year | $17.50 | N/A |
| P/E Ratio | $5.49 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.51 | $1.69 |
| 52 Week High | $19.50 | $7.19 |
Technical Indicators
Market Signals| Indicator | HCM | VZLA |
|---|---|---|
| Relative Strength Index (RSI) | 48.67 | 35.75 |
| Support Level | $13.09 | $3.35 |
| Resistance Level | $14.63 | $4.33 |
| Average True Range (ATR) | 0.43 | 0.22 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 60.66 | 1.10 |
Price Performance
Historical ComparisonAbout HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About VZLA Vizsla Silver Corp.
Vizsla Silver Corp is a junior mineral exploration and development company focused on advancing its Panuco silver-gold project located in Sinaloa, Mexico. The property contains quartz-carbonate veins with workings defining both steeply plunging and sub-horizontal ore shoots. Mineralization occurs as silver sulphides including argentite and acanthite, native gold, electrum and native silver associated with pyrite, minor galena, sphalerite and rare chalcopyrite. It has one operating segment, which is principally mineral exploration.